LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

NCT02205762 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1400

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Prednisone
DRUG: Vinblastine
DRUG: mercaptopurine
DRUG: INDOMETHACIN
DRUG: Methotrexate
DRUG: Cytosine Arabinoside
DRUG: 2-chlorodeoxyadenosine
PROCEDURE: hematopoietic stem cell transplantation (RIC-HSCT)
BIOLOGICAL: Intravenous immunoglobulin

Sponsor

North American Consortium for Histiocytosis

Collaborators

[object Object]